Togni Lucrezia, Mascitti Marco, Santarelli Andrea, Contaldo Maria, Romano Antonio, Serpico Rosario, Rubini Corrado
Department of Clinical Specialistic and Dental Sciences, Marche Polytechnic University, Ancona, Italy.
National Institute of Health and Science of Aging, IRCCS INRCA, Ancona, Italy.
Front Physiol. 2019 Jul 3;10:855. doi: 10.3389/fphys.2019.00855. eCollection 2019.
Salivary glands (SG) arise from ectodermal tissue between 6 and 12th weeks of intrauterine life through finely regulated epithelial-mesenchymal interactions. For this reason, different types of structural congenital anomalies, ranging from asymptomatic anatomical variants to alterations associated with syndromic conditions, have been described. Notable glandular parenchyma anomalies are the SG aplasia and the ectopic SG tissue. Major SG aplasia is a developmental anomaly, leading to variable degrees of xerostomia, and oral dryness. Ectopic SG tissue can occur as accessory gland tissue, salivary tissue associated with branchial cleft anomalies, or true heterotopic SG tissue. Among salivary ducts anomalies, congenital atresia is a rare developmental anomaly due to duct canalization failure in oral cavity, lead to salivary retention posterior to the imperforate orifice. Accessory ducts originate from the invagination of the developing duct in two places or from the premature ventral branching of the main duct. Heterotopic ducts may arise from glandular bud positioned in an anomalous site lateral to the stomodeum or from the failure of the intraoral groove development, hindering their proximal canalization. These anomalies require multidisciplinary approach to diagnosis and treatment. While ectopic or accessory SG tissue/ducts often do not require any treatment, patients with SG aplasia could benefit from strategies for restoring SG function. This article attempts to review the literature on SG parenchyma and ducts anomalies in head and neck region providing clinicians with a comprehensive range of clinical phenotypes and possible future applications of bioengineered therapies for next-generation of regenerative medicine.
唾液腺(SG)在子宫内生命的第6至12周期间由外胚层组织通过精细调控的上皮-间充质相互作用发育而来。因此,已经描述了不同类型的结构性先天性异常,从无症状的解剖变异到与综合征相关的改变。值得注意的腺实质异常是唾液腺发育不全和异位唾液腺组织。主要唾液腺发育不全是一种发育异常,导致不同程度的口干症和口腔干燥。异位唾液腺组织可表现为副腺组织、与鳃裂异常相关的唾液组织或真正的异位唾液腺组织。在唾液导管异常中,先天性闭锁是一种罕见的发育异常,由于口腔导管管道化失败,导致在无孔口后方出现唾液潴留。副导管起源于发育中的导管在两个部位的内陷或主导管的过早腹侧分支。异位导管可能源于位于口凹外侧异常部位的腺芽或口腔沟发育失败,阻碍其近端管道化。这些异常需要多学科方法进行诊断和治疗。虽然异位或副唾液腺组织/导管通常不需要任何治疗,但唾液腺发育不全的患者可能会从恢复唾液腺功能的策略中受益。本文试图回顾关于头颈部唾液腺实质和导管异常的文献,为临床医生提供全面的临床表型以及生物工程疗法在下一代再生医学中的可能未来应用。